Cart
sales@molnova.com
Nitrendipine
CAS No. 39562-70-4
Nitrendipine( Nitrendipine, Bayotensin, Baypress, Nidrel, Deiten )
Catalog No. M14360 CAS No. 39562-70-4
Nitrendipine is a calcium channel blocker with marked vasodilator action.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 48 | In Stock |
|
| 10MG | 30 | In Stock |
|
| 25MG | 48 | In Stock |
|
| 50MG | 60 | In Stock |
|
| 100MG | 113 | In Stock |
|
| 200MG | 172 | In Stock |
|
| 500MG | 276 | In Stock |
|
| 1G | 427 | In Stock |
|
Biological Information
-
Product NameNitrendipine
-
NoteResearch use only, not for human use.
-
Brief DescriptionNitrendipine is a calcium channel blocker with marked vasodilator action.
-
DescriptionNitrendipine is a calcium channel blocker with marked vasodilator action.
-
In Vitro——
-
In Vivo——
-
SynonymsNitrendipine, Bayotensin, Baypress, Nidrel, Deiten
-
PathwayGPCR/G Protein
-
TargetCalcium Channel
-
RecptorCalcium Channel
-
Research AreaCardiovascular Disease
-
Indication——
Chemical Information
-
CAS Number39562-70-4
-
Formula Weight360.36
-
Molecular FormulaC18H20N2O6
-
Purity>98% (HPLC)
-
SolubilityDMSO: 72 mg/mL (199.79 mM)
-
SMILESCCOC(C1=C(C)NC(C)=C(C(OC)=O)C1C2=CC([N+]([O-])=O)=CC=C2)=O
-
Chemical Name3-ethyl 5-methyl 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Perez-Reyes E, et al. J Pharmacol Exp Ther. 2009 Feb;328(2):621-7.
molnova catalog
related products
-
GV-58
GV-58 is a potent, selective N-Type and P/Q-type Ca2+ Channel agonist with EC50 of 7.2 and 8.8 uM.
-
Mirogabalin besylate
Mirogabalin besylate (DS-5565) is a novel potent, selective ligand of the α2δ subunit of voltage-gated calcium channels with Kd of 13.5/22.7/27.0/47.6 nM for huamn α2δ-1, human α2δ-2, rat α2δ-1 and rat α2δ-2 subunits, respectively.
-
PD173212
PD 173212 is a blocker that blocks N-type voltage sensitive calcium channel (Cav2.2). PD173212 (0.0017-1.7 μmol/kg, Intraperitoneal Injection.) dose-dependently reduced DNBS-induced visceral hypersensitivity in mice.
